Background: Non-human primates are valuable models for the study of insulin resistance and human obesity. In baboons, insulin sensitivity levels can be evaluated directly with the euglycemic clamp and is highly predicted by adiposity, metabolic markers of obesity and impaired glucose metabolism (i.e. percent body fat by DXA and HbA 1c ). However, a simple method to screen and identify obese insulin resistant baboons for inclusion in interventional studies is not available.
Background
Non-human primates are valuable models for the study of human disease, because of their close genetic and physiologic similarity to man [1] [2] [3] . The baboon (Papio hamadryas) is a long lived primate with an average lifespan of ~25 years that can be maintained in controlled conditions for generations, in order to evaluate the interaction between genetic and environmental factors in the pathogenesis of complex diseases [1, 4, 5] . Baboons display biochemical and molecular characteristics of the insulin resistance (metabolic) syndrome and type 2 diabetes (T2DM), as they progress from a lean to an obese phenotype and during the normal process of aging [5] [6] [7] [8] . Not surprisingly, these primates develop several pathologies similar to those in man and they have been widely used and established as models for osteoporosis, atherosclerosis and obesity [4, [9] [10] [11] . Recently, using the hyperinsulinemic euglycemic clamp technique, we characterized the baboon as a model of insulin resistance and identified key biochemical and molecular defects in the insulin signaling cascade in some target tissues (skeletal muscle and adipose tissue) [12] . Our results demonstrated that insulin resistance is directly related to fat mass, with percent body fat measured by dual-energy X ray absorptiometry (DXA) being the best predictor for insulin resistance. However, in large scale studies, the feasibility of DXA scan as a screening method to identify insulin resistant baboons is limited, because it is laborious and expensive. At our Institution, as part of the routine animal husbandry, all baboons receive a biannual health check. While sedated for this health check, animals are also weighted and basic morphometric measurements are obtained along with a blood chemistry panel for metabolic profiling [4] . We sought to develop a simple screening strategy to identify lean insulin-sensitive and obeseinsulin resistant baboons for inclusion in genetic, physiologic and pharmacologic studies of obesity and insulin resistance using morphometric and biochemical markers of adiposity and glucose metabolism. Our results demonstrate the value of simple morphometric (abdominal circumference) and metabolic measurements (fasting plasma glucose and insulin) to predict insulin sensitivity in this baboon non human primate model.
Methods

Study population and morphometrics
Twenty adult nondiabetic baboons (10 females and 10 males) with varying degrees of adiposity and insulin sensitivity comprised the original study population. For inclusion, sedated baboons were evaluated with morphometric measurements including weight, crown to heel length, BMI, abdominal circumference (measured with a flexible non-stretchable measuring tape at a level midway between the lower rib margin and iliac crest) and a biochemical panel during the course of a scheduled health check. Morphometrics and metabolic assessments were performed during the last scheduled health check for each baboon. The clinical and biochemical characteristics of this study population have been published elsewhere [12] .
In addition, we studied a second group of baboons (n = 159) during a scheduled health check. Recorded measurements included body weight, fasting plasma glucose and insulin concentrations. Only baboons with a stable body weight over the previous six months, fasting plasma glucose <150 mg/dl and fasting plasma insulin concentrations <100 μU/ml were considered for inclusion. The purpose of this group was to validate a simpler predictive model using fasting plasma glucose and body weight derived from the first group (n = 20).
Assessment of insulin sensitivity and calculations
Under general anesthesia, baboons received a 2-hour 60 mU/m 2 .min hyperinsulinemic euglycemic clamp after an overnight fast (~12 hour), as previously described [12, 13] . During the steady state of the clamp (90-120 min) at the prevailing insulin concentrations, the skeletal muscle and adipose tissue are maximally stimulated, and demonstrated by an increased activation in key insulin signaling proteins starting at 30 min after insulin infusion [12] . Fasting plasma glucose (FPG) was measured by the glucose oxidase method (Beckman Glucose Analyzer 2, Beckman-Coulter, Fullerton, CA); plasma (FFA) free fatty acids were measured at baseline and by the end of the clamp using an enzymatic colorimetric assay (Wako Chemicals USA). Finally, fasting plasma insulin (FPI) concentration was determined using a commercial radioimmunoassay (Diagnostic Products, Los Angeles, CA) at baseline and at 10-15 minutes intervals throughout the euglycemic clamp. Steady state plasma insulin was calculated as the mean insulin concentrations from 90 to 120 min. Whole body insulin sensitivity was calculated as the mean glucose infusion rate during the steady state, reflecting the insulin-stimulated rate of glucose disposal (Rd). Alternatively, we calculated the whole body insulin sensitivity as the ratio between the Rd in milligrams of glucose per kg of lean body mass and SSPI (Rd/SSPI). Using the FPG and FPI, we also calculated the quantitative insulin sensitivity check index (QUICKI) as 1/log (FPI) + log (FPG) [14] . The adipocyte insulin resistance index (AIRI) that estimates the ability of adipocytes to suppress the rate of lipolysis in response to insulin was calculated as the fasting FFA concentrations multiplied by FPI (AIRI = FFA*FPI). Since baboons show a marked gender dimorphism in some morphometric and metabolic parameters, all analyses were adjusted for gender differences and variables with a non-normal distribution were log transformed prior to analysis.
Development of predictive models of insulin sensitivity by morphometrics and metabolic assessment
In order to determine the predictive value of metabolic and morphometric measurements, we constructed two different models using a stepwise linear regression analysis, with Rd as the dependent variable. In the first model (Model 1), abdominal circumference, adjusted for gender, was the independent variable. In the second model (Model 2), we included abdominal circumference and FPI (log transformed) as the independent variables. Lastly, we created a model to predict Rd/SSPI (Model 3), by using fasting plasma glucose concentrations and total body weight as independent variables. We applied the formula for the prediction of Rd/SSPI to a second group of baboons (n = 159), in which body weight was stable over the previous 6 months, during a bi-annual scheduled health check that included measurements for body weight, fasting plasma glucose and insulin concentrations. Only baboons with a fasting plasma glucose <150 mg/dl and fasting plasma insulin concentrations <100 μU/ml were considered for the validation of this predictive analysis model.
Pearson's and/or Spearman partial correlations were calculated as appropriate. We used a step-wise approach to include significant correlations into the linear regression models. Statistical analyses were performed using Statview 5.0 (SAS Institute, Cary, NC) statistical package. A p value of < 0.05 was considered statistically significant.
Results
Insulin sensitivity and body fat composition measurements
In our study population, the Rd spanned a wide range of insulin sensitivity. Using a cut-off point for Rd <5 mg/ kg.min to screen for insulin resistant primates we identified 10 insulin resistant baboons range and 10 insulin sensitive baboons. In baboons, similar to humans, there was a marked gender dimorphism in percent body fat, where females had significantly higher percent body fat compared to males (12 ± 2 vs. 6 ± 1.5%, p = 0.05).
Morphometrics, markers of adiposity and insulin resistance in the adipocyte
In our study population, abdominal circumference correlated directly with the adipocyte insulin resistance index (r = 0.693, p < 0.02). When percent body fat content was measured using DXA, it also showed a strong correlation with the adipocyte insulin resistance index (R = 0.755, p < 0.001) ( Table 1 ), but not with total and lean body mass.
Regression analysis and predictive models of insulin sensitivity
In a multivariate model, after adjusting for gender, the best determinants of insulin sensitivity were fasting plasma glucose (adjusted R 2 = 0.15), insulin concentrations (log transformed, adjusted R 2 = 0.32), total body fat (adjusted R 2 = 0.39), percent fat (adjusted R 2 = 0.46), and abdominal circumference (adjusted R 2 = 0.59).
In the first model (Model 1), we used abdominal circumference and gender to predict of tissue sensitivity to insulin ( Figure 1 -A, predicted Rd = -3.618*sex-0.376 * "Abdominal Circ" + 29.508, with sex = 1 for male, and 0 for females). The explained variability was 59%, with insulin sensitivity levels negatively correlated with abdominal circumference (partial R = -0.79, p < 0.0001) and gender (partial R = -0.55, p < 0.03). The regression analysis showed a high degree of correlation between the predicted and measured levels of insulin sensitivity (Figure 1A , R = 0.796, p < 0.0001). Since the increase in abdominal circumference is directly correlated with percent body fat and visceral obesity in baboons, this finding suggests that, similar to humans, a pattern of central adiposity predicts the presence of an insulin resistance metabolic syndrome in the baboon. The addition of body fat measurements did not improve the model. On the other hand, the inclusion of log (FPI) in the second model (Model 2), overall improved its predictive power (adjusted R 2 = 0.64, predicted Rd = -4.894*sex-0.309 * "Abdominal Circ" -1.678* log (FPI) + 30.294, with sex = 1 for male, and 0 for females). However, despite the fact that abdominal circumference (partial R = -0.72, p = 0.001) and gender (partial R = -0.63, p = 0.007) were strong independent predictors of insulin sensitivity, the FPI was not independently correlated to Rd (partial R = -0.42, p = 0.09). The agreement between predicted and measured levels of insulin sensitivity is shown in Figure 1B (R = 0.836, p < 0.0001).
In Model 3, we considered weight and fasting plasma glucose as independent variables since these are the routine measurements collected during biannual health check. Model 3 also was able to predict well insulin sensitivity (Predicted Rd/SSPI = 17.18-0.305* Body Weight-0.056*FPG), explaining 51% of the insulin sensitivity variability as shown in Figure 1C (R = 0.717, p < 0.001).
Linear regression models to predict insulin resistance in adult nondiabetic baboons using (A) abdominal circumference (Model 1), (B) abdominal circumference + log FPI (Model 2), and (C) body weight + fasting plasma glucose (Model 3), as independent variables 
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For simplicity, we generated a gender specific predictive scale, using the abdominal circumference model to predict insulin sensitivity (Figure 2 ). According to this model, an abdominal circumference >55 cm in males and >65 cm in females is highly predictive for insulin resistance in baboons.
Body weight and fasting plasma glucose as predictors of insulin sensitivity in baboons
Although abdominal circumference was the strongest predictor of whole body insulin sensitivity, this measurement was not always readily available in health check records as a routine screening procedure. Therefore, we sought to validate Model 3 into a larger population in which abdominal circumferences were not available. Using this approach (Model 3 = body weight + FPG), we tested the predictive model in 159 baboons with a wide range of weight, fasting glucose and fasting insulin ( Table 2) . We stratified the animal population according to quartiles of predicted insulin sensitivity (Q1 = 38, Q2 = 41, Q3 = 39 and Q4 = 41). We found that the mean predicted Rd/SSPI was 8-fold higher in the insulin sensitive group compared to the insulin resistant quartile (Q1 = >8.4 vs. Q4 = <1.1 mg/kg LBM per μU/ml (plasma insulin), p < 0.001). For the whole population, the 25 th percentile was <2.906 vs. 75 th >7.252 mg/kg LBM per μU/ml (plasma insulin). The gender distribution showed gender dimorphism (males Rd/SSPI 25 th = 1.51 vs. 75 th = 4.537 mg/kg LBM per μU/ml (plasma insulin) and females Rd/SSPI 25 th = 4.66 vs. 75 th = 7.94 mg/kg LBM per μU/ml (plasma insulin).
Body weight and fasting plasma glucose are better predictors of peripheral insulin sensitivity in baboons
Although there were clear cut differences in whole body insulin sensitivity (predicted Rd/SSPI) and a progressive increase in FPG from the lowest to the highest quartiles across the study population (Figures 3-A and 3-B) , when we used surrogate indices of insulin sensitivity calculated during the fasting state (i.e. ln_FPI and QUICKI), no significant differences were found between groups ( Figures  3-C and 3-D) . Of note, the same results were obtained after gender specific comparison were performed ( Figures  3-E and 3-F) . This further supports the known limitation of FPI and QUICKI as surrogate measurements to differentiate peripheral (muscle) from central (liver) insulin resistance. Therefore, given their nature of steady fasting state measurements, FPI and QUICKI mainly reflect central (liver) insulin resistance [15, 16] .
Discussion
In the present study, we evaluated the predictive value of simple markers of adiposity for the presence of insulin resistance (measured with the gold-standard euglycemic insulin clamp technique) in a population of adult nondiabetic baboons. Our results support the use of abdominal circumference as a simple and feasible measurement to predict insulin resistance in these non-human primates. Our findings are consistent with previous observations which demonstrated that baboons become insulin resistant as they develop a central obese phenotype [17] . In fact, it is well known that baboons develop early features of insulin resistance and metabolic syndrome along with a high body mass when they are exposed to unnatural Relationship between abdominal circumference (independent variable) and predicted rate of insulin-stimulated glucose disposal (Rd) Figure 2 Relationship between abdominal circumference (independent variable) and predicted rate of insulinstimulated glucose disposal (Rd). 
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A C B nutritional and social environments (i.e. ingestion of high fat saturated human food waste in those living close to touristic facilities) compared to wild baboons subsisting mainly on forage [18] . During weight gain, baboons accumulate fat in the abdominal area (both visceral and subcutaneous) and the abdominal circumference is correlated with abdominal fat content and percent body fat. Although it is known that percent body fat correlates well with total body weight and abdominal circumference in both gender, there are not definitive established cut points for the diagnosis of obesity in baboons [4] . Therefore, in our study we have included baboons exhibiting a wide range of adiposity measured by abdominal circumference and percent body fat. Of note, when simple metabolic measurements and insulin sensitivity indices in the fasting state (such as FPG, FPI and QUICKI) are used in conjunction with abdominal circumference, the predictive power of the model increases and explains a very large portion (~70%) of the variation in insulin sensitivity.
Our study has several strengths: (i) the study population is a well characterized group of baboons from the morphometric, biochemical and molecular standpoint with clear cut differences between the lean, insulin sensitive and the obese, insulin resistant baboons; (ii) this nonhuman primate model mimics closely findings in humans that relate the presence of a central obese phenotype with impaired glucose metabolism and insulin resistance, indicating the presence of the insulin resistance (metabolic) syndrome equivalent in the baboon [19] [20] [21] [22] [23] . One potential weakness of our analyses is that we studied a relative small number of primates with the euglycemic clamp. However, we included baboons of both genders with a wide spectrum of insulin sensitivity, abdominal circumference and percent body fat. Moreover, we were able to validate a predictive model of insulin resistance based on total body weight and fasting glucose, which are useful surrogates to abdominal circumference when this is not readily available. Our findings are in agreement with other report and covered the range from the lean, insulinsensitive to overweight/obese, insulin-resistant baboons [4, 5] . Our findings also support the fact that insulin resistance is progressive, as baboons evolve from a lean to an overweight/obese phenotype. The insulin resistance is evident not only at the glucose uptake level in skeletal muscle, but also in the adipose tissue, as is demonstrated by the lack of suppression of FFA concentrations in the presence of high insulin levels in the baboons with the highest percent body fat, expressed as the adipocyte insulin resistance index. The estimation of adipocyte insulin resistance index provides some insight into the dysregulation of adipocyte biology present in obesity and the metabolic syndrome Therefore, the measurements of FFA and insulin could be of help to identify those baboons likely to have not only physical, but also metabolic and molecular features of the insulin resistant phenotype.
Although our results were obtained in baboons, they are likely to be applicable to other non-human primates, since the array of metabolic abnormalities associated with an obese phenotype is well documented across primate species [8, [24] [25] [26] [27] . Moreover, the use of morphometrics, specifically abdominal circumference is also very likely to predict insulin resistance when other methods different from the euglycemic clamp are used to quantitate insulin sensitivity (i.e. minimal model assessment from oral or IV glucose tolerance test), given the documented correlation between these techniques [28] .
Our results are in agreement with several larger human cohorts demonstrating the predictive power of abdominal and trunk fat deposits to predict the presence of different traits of the insulin resistance metabolic syndrome and its co morbidities [21, [29] [30] [31] . Although the use of abdominal circumference is a simple and feasible measurement that provides useful information about the insulin sensitivity and overall the metabolic status in baboons, it is not always readily available for screening purposes in primate studies. For this reason, we developed a model that included variables generally available and routinely collected as part of the semi-annual scheduled health checks at our institution. While the model considering body weight and fasting plasma glucose (Model 3) was not as powerful as abdominal circumference to explain the variability in insulin sensitivity, it was able to dissect clear cut differences in insulin sensitivity across the study group.
These data further support the value of this baboon nonhuman primate as a model for the study of obesity and metabolic diseases in humans. Based on our results, we propose an algorithm for screenings of primates in order to identify those who are likely to present features of obesity or insulin resistance for inclusion in research studies ( Figure 4 ). Since genetic, nutritional and environmental factors seem to play a complex integrated role in the pathogenesis of obesity and its associated traits, we strongly believe these findings could be applied to both wild and captive baboons.
In summary, abdominal circumference is a major determinant of insulin sensitivity in both male and female baboons, and its association with fasting measurements of glucose metabolism and insulin sensitivity, i.e. FPI and FPG, provide a useful instrument to screen primates to identify insulin sensitive and insulin resistant for inclusion in large scale protocols designed to examine the effects of dietary and pharmacological interventions in the study of obesity, insulin resistance and type 2 diabetes in humans.
